Andrea is very privileged to be attending Dr Tammy Kielian’s talk on her pre-clinical work on gene therapy for CLN3 (Juvenile Batten Disease) and also BioMarin will present the data from the CLN2 trial for the first time. We will bring you details of the presentations as soon as we can.